VECURONIUM BROMIDE (VECURONIUM BROMIDE)
Labeling: Label Lacks Warning or Rx Legend
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
Severity not yet assessed
We have not scored this recall against our rubric yet, so we are not showing a severity rating or our usual guidance. The agency’s own notice below is the authoritative source — read it first.
Plain-English summary
Labeling: Label Lacks Warning or Rx Legend
The recalled product
- Product
- VECURONIUM BROMIDE (VECURONIUM BROMIDE)
- Brand
- VECURONIUM BROMIDE
- Manufacturer
- Meitheal Pharmaceuticals, Inc
- Category
- Drug — Drugs
- Affected units
- 10,200
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot# T1P0113C: Exp. 28-Feb-29 Lot# T1P0612C: Exp. 31-Oct-28
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · VECURONIUM BROMIDE
- CriticalSun Pharmaceutical Recalls Vecuronium Bromide Due to Glass Particulates
FDA (Drugs) · 2019-01-16
- SevereSun Pharmaceutical Recalls Vecuronium Bromide Injection Due to Glass Particles
FDA (Drugs) · 2019-01-16
Same manufacturer · Meitheal Pharmaceuticals, Inc
See all →- ModerateCetrorelix injection kits recalled over missing or duplicated needles inside
FDA (Drugs) · 2026-02-18
- ModerateGlycopyrrolate Injection Recalled for Failed Impurities and Degradation Specifications
FDA (Drugs) · 2021-09-22
- SevereCisatracurium Besylate Injection Recalled Due to Labeling Error
FDA (Drugs) · 2021-03-03